Who owns AMPHASTAR PHARMACEUTICALS IN?
- CUSIP Number: 03209rab9
Tip: Access positions for across all investors
Analyze quarterly positions in Amphastar Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Amphastar Pharmaceuticals In stock
Who bought or sold AMPHASTAR PHARMACEUTICALS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 94M | $87M | 0% | Dec 2025 |
|
| Context Capital Management | 67M | $61M | 111% | Mar 2026 |
|
| Camden Asset Management | 42M | $38B | 14% | Mar 2026 |
|
| Oaktree Capital Management | 38M | $35M | -13% | Mar 2026 |
|
| Wellesley Investment Advisors | 26M | $24B | 30% | Mar 2026 |
|
| Empyrean Capital Partners | 20M | $18M | 25% | Mar 2026 |
|
| Calamos Advisors | 10M | $9.1M | 0% | Mar 2026 |
|
| Morgan Stanley | 6.6M | $6.0M | 100% | Mar 2026 |
|
| Russell Investments | 5.7M | $5.2M | -11% | Mar 2026 |
|
| BlackRock | 5.5M | $5.0M | 27% | Mar 2026 |
|
| Silverback Asset Management | 5.1M | $4.6M | -44% | Mar 2026 |
|
| Advent Capital Management | 4.1M | $3.7M | -1% | Mar 2026 |
|
| FMR | 3.8M | $3.5M | 0% | Dec 2025 |
|
| Citigroup | 3.5M | $3.2M | 100% | Mar 2026 |
|
| Palisade Capital Management | 2.4M | $2.2M | -3% | Dec 2025 |
|
| Pinnacle Holdings | 2.1M | $1.9M | 100% | Mar 2026 |
|
| Cutler Capital Management | 1.9M | $1.8M | -1% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.2M | $1.1M | 0% | Mar 2026 |
|
| Royal Bank of Canada | 1.1M | $1.0M | -47% | Mar 2026 |
|
| CSS | 510k | $461k | -80% | Mar 2026 |
|
| SSI Investment Management | 358k | $324k | -2% | Mar 2026 |
|
| Bank of New York Mellon | 300k | $272k | 0% | Mar 2026 |
|
| Barclays | 242k | $224k | -26% | Dec 2025 |
|
| Puplava Financial Services | 235k | $218k | 100% | Dec 2025 |
|
| Cetera Investment Advisers | 111k | $100k | 0% | Mar 2026 |
|
| Ares Systematic Credit | 100k | $91k | 0% | Mar 2026 |
|
| Raymond James Financial | 38k | $35k | 171% | Dec 2025 |
|
| Rsm Us Wealth Management | 37k | $34k | 0% | Mar 2026 |
|
| Capital Investment Advisory Services | 16k | $15k | 0% | Mar 2026 |
|
| Goldman Sachs Group | 16k | $15k | 0% | Mar 2026 |
|
| Insigneo Advisory Services | 12k | $11k | -20% | Mar 2026 |
|
| Fifth Third Bancorp | 11k | $9.9k | 100% | Mar 2026 |
|
| Brian McDonald | 11k | $10k | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 4.0k | $3.6k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 4.0k | $3.6k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 6.00 | $5.5k | 0% | Dec 2025 |
|
Who sold out of Amphastar Pharmaceuticals In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tenor Capital Management | Dec 2025 | 15M | $14M |
| MacKay Shields | Dec 2025 | 8.7M | $8.1M |
| Kim | Dec 2025 | 2.5M | $2.3M |
| Lazard Asset Management | Dec 2025 | 2.5M | $23k |
| Jpmorgan Chase & Co | Sep 2025 | 1.7M | $1.6M |
| Leucadia National Corporation | Dec 2025 | 318k | $294k |
| Zurcher Kantonalbank | Dec 2025 | 250k | $231k |
| Sei Investments | Dec 2025 | 139k | $128k |
| Wealth Enhancement Advisory Services | Dec 2025 | 10k | $9.3k |